Mostrar el registro sencillo del ítem
Comparison of Two Radiotherapeutic Hypofractionated Schedules in the Application of Tumor Bed Boost
dc.creator | Zygogianni, A. | en |
dc.creator | Kouloulias, V. | en |
dc.creator | Kyrgias, G. | en |
dc.creator | Armpilia, C. | en |
dc.creator | Antypas, C. | en |
dc.creator | Theodorou, K. | en |
dc.creator | Kouvaris, J. | en |
dc.date.accessioned | 2015-11-23T10:55:29Z | |
dc.date.available | 2015-11-23T10:55:29Z | |
dc.date.issued | 2013 | |
dc.identifier | 10.1016/j.clbc.2013.02.007 | |
dc.identifier.issn | 1526-8209 | |
dc.identifier.uri | http://hdl.handle.net/11615/35041 | |
dc.description.abstract | The application of the tumor bed boost by using 2 different hypofractionated planning techniques permit more efficient use of resources in hospitals. The evaluation of the radiation toxicity and the efficacy of the 2 schedules were well tolerated and effective. However, the sequential boost appears superior to the concomitant boost in terms of skin toxicity. Aim: Evaluation of related radiation toxicity and efficacy in terms of local control of 2 radiotherapeutic hypofractionated schedules in the application of tumor bed boost by using 2 different planning techniques. Method: Eighty-one patients with stage I-II disease were retrospectively selected with either concomitant (group A) or sequential (group B) boost for the tumor bed. In group A, 27 patients were treated with a total dose of 46 Gy to the whole breast and 54 Gy to the tumor bed in 20 concomitant fractions. In group B, 54 patients were treated with a total dose of 42.4 Gy in 16 fractions to the whole breast and 53 Gy to the tumor bed by 4 sequential fractions. The boost was administered with multiple photon-beam fields. The median follow-up time was 24 months. Results: The statistical analysis for the 2 groups of the study showed that skin toxicity was significantly worse in group A (P < .05, Kruskal-Wallis H test). For groups A and B at the completion of radiation therapy, grade 1 skin toxicity was observed in 18/27 patients (66.6%) and 13/54 patients (24.1%), respectively, whereas grade 2/3 was observed in 9/27 patients (33.3%) vs. 5/54 patients (9.3%), respectively (P < .001). One year after irradiation, in group A and in group B, the skin toxicity was of grade 1 in 6/27 patients (22.2%) vs. 2/54 patients (3.7%), respectively (P = .008). Within 2 years, the breast returned to its original form in all patients. No patient showed local disease recurrence. Conclusions: The accelerated hypofractionated schedules in the application of the tumor bed boost by using the 2 different planning techniques appears to be effective and well tolerated. | en |
dc.source.uri | <Go to ISI>://WOS:000321239600010 | |
dc.subject | Breast cancer | en |
dc.subject | Concomitant | en |
dc.subject | Radiotherapy | en |
dc.subject | Sequential | en |
dc.subject | Toxicity | en |
dc.subject | Tumor | en |
dc.subject | bed | en |
dc.subject | BREAST-CONSERVING TREATMENT | en |
dc.subject | RANDOMIZED-TRIAL | en |
dc.subject | CANCER RADIOTHERAPY | en |
dc.subject | CONSERVATIVE TREATMENT | en |
dc.subject | INTENSITY MODULATION | en |
dc.subject | CONCOMITANT BOOST | en |
dc.subject | ELECTRON BOOST | en |
dc.subject | ACUTE TOXICITY | en |
dc.subject | LOCAL-CONTROL | en |
dc.subject | I-II | en |
dc.subject | Oncology | en |
dc.title | Comparison of Two Radiotherapeutic Hypofractionated Schedules in the Application of Tumor Bed Boost | en |
dc.type | journalArticle | en |
Ficheros en el ítem
Ficheros | Tamaño | Formato | Ver |
---|---|---|---|
No hay ficheros asociados a este ítem. |